Annual report pursuant to Section 13 and 15(d)

Merger, Allocation of Purchase Price (Details)

Merger, Allocation of Purchase Price (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 05, 2020
Dec. 31, 2020
Dec. 31, 2019
Allocation of Purchase Price [Abstract]      
Cash acquired $ 2,014 $ 2,014 $ 0
Net assets assumed 68    
IPR&D 8,376 [1] $ 10,502 $ 0
Purchase price $ 10,458    
[1] Represents the pre-Merger research and development projects of Rexahn which were in-process, but not yet completed, and which the Company may advance post-Merger. This includes the development of RX-3117, RX-0301 and RX-0047. Current accounting standards require that the fair value of IPR&D projects acquired in an asset acquisition with no alternative future use be allocated a portion of the consideration transferred and charged to expense on the acquisition date. The acquired assets did not have outputs or employees.